Development of a SARS-CoV-2 total antibody assay and the dynamics of antibody response over time in hospitalized and non-hospitalized patients with COVID-19
Detection Principle
ImmunoAssay-Antibody
Target
IgG, IgA, IgM on RBD, NP
Testing Method Category
Testing Method
in house
Testing Method - Additional Info
Bridging assay
Reported Performance
Specificity 99% (total Ab), 98.1-99.3% (RDB-Ab), 93.7-97.5% (NP-Ab)
Sample Size
591 samples
Peer-reviewed
no
The database contains available information from scientific literature that is being updated periodically. Please note that the provided information (as retrieved from analysed papers) is provided only for devices commercially available with CE-IVD mark. Acknowledgements